166 related articles for article (PubMed ID: 15621574)
1. High levels of autoantibodies against drug-metabolizing enzymes in SLA/LP-positive AIH-1 sera.
Shinoda M; Tanaka Y; Kuno T; Matsufuji T; Matsufuji S; Murakami Y; Mizutani T
Autoimmunity; 2004; 37(6-7):473-80. PubMed ID: 15621574
[TBL] [Abstract][Full Text] [Related]
2. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.
Manns MP; Obermayer-Straub P
Hepatology; 1997 Oct; 26(4):1054-66. PubMed ID: 9328334
[TBL] [Abstract][Full Text] [Related]
3. Immunoreactivity to various human cytochrome P450 proteins of sera from patients with autoimmune hepatitis, chronic hepatitis B, and chronic hepatitis C.
Miyakawa H; Kitazawa E; Kikuchi K; Fujikawa H; Kawaguchi N; Abe K; Matsushita M; Matsushima H; Igarashi T; Hankins RW; Kako M
Autoimmunity; 2000; 33(1):23-32. PubMed ID: 11204250
[TBL] [Abstract][Full Text] [Related]
4. Increased incidence of anti-LKM autoantibodies in a consecutive cohort of hepatitis C patients from central Greece.
Dalekos GN; Makri E; Loges S; Obermayer-Straub P; Zachou K; Tsikrikas T; Schmidt E; Papadamou G; Manns MP
Eur J Gastroenterol Hepatol; 2002 Jan; 14(1):35-42. PubMed ID: 11782573
[TBL] [Abstract][Full Text] [Related]
5. Target proteins in human autoimmunity: cytochromes P450 and UDP- glucuronosyltransferases.
Obermayer-Straub P; Strassburg CP; Manns MP
Can J Gastroenterol; 2000 May; 14(5):429-39. PubMed ID: 10851284
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies against CYP2D6 and other drug-metabolizing enzymes in autoimmune hepatitis type 2.
Mizutani T; Shinoda M; Tanaka Y; Kuno T; Hattori A; Usui T; Kuno N; Osaka T
Drug Metab Rev; 2005; 37(1):235-52. PubMed ID: 15747502
[TBL] [Abstract][Full Text] [Related]
7. [Autoimmune hepatitis and overlap syndrome: diagnosis].
Berg PA; Klein R
Praxis (Bern 1994); 2002 Aug; 91(34):1339-46. PubMed ID: 12233264
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies directed against the UDP-glucuronosyltransferases in human autoimmune hepatitis.
Fabien N; Desbos A; Bienvenu J; Magdalou J
Autoimmun Rev; 2004 Jan; 3(1):1-9. PubMed ID: 14871643
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview.
Dalekos GN; Zachou K; Liaskos C; Gatselis N
Eur J Intern Med; 2002 Aug; 13(5):293-303. PubMed ID: 12144908
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease.
Zachou K; Rigopoulou E; Dalekos GN
J Autoimmune Dis; 2004 Oct; 1(1):2. PubMed ID: 15679907
[TBL] [Abstract][Full Text] [Related]
11. [A retrospective study on the role of antibodies against soluble liver antigen (anti-SLA antibodies) and other autoantibodies in the diagnostics of autoimmune hepatitis].
Bakker-Jonges LE; ter Borg PC; van Buuren HR; Hooijkaas H
Ned Tijdschr Geneeskd; 2006 Mar; 150(9):490-4. PubMed ID: 16553048
[TBL] [Abstract][Full Text] [Related]
12. Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes.
Klein R; Zanger UM; Berg T; Hopf U; Berg PA
Clin Exp Immunol; 1999 Nov; 118(2):290-7. PubMed ID: 10540193
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies and autoantigens in autoimmune hepatitis.
Strassburg CP; Manns MP
Semin Liver Dis; 2002 Nov; 22(4):339-52. PubMed ID: 12447706
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies and their antigens in autoimmune hepatitis.
Bogdanos DP; Mieli-Vergani G; Vergani D
Semin Liver Dis; 2009 Aug; 29(3):241-53. PubMed ID: 19675997
[TBL] [Abstract][Full Text] [Related]
15. Characterization of autoantibodies against uridine-diphosphate glucuronosyltransferase in patients with inflammatory liver diseases.
Bachrich T; Thalhammer T; Jäger W; Haslmayer P; Alihodzic B; Bakos S; Hitchman E; Senderowicz AM; Penner E
Hepatology; 2001 May; 33(5):1053-9. PubMed ID: 11343231
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis.
Terjung B; Bogsch F; Klein R; Söhne J; Reichel C; Wasmuth JC; Beuers U; Sauerbruch T; Spengler U
Eur J Med Res; 2004 Sep; 9(9):439-48. PubMed ID: 15546809
[TBL] [Abstract][Full Text] [Related]
17. Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1.
Manns MP; Johnson EF; Griffin KJ; Tan EM; Sullivan KF
J Clin Invest; 1989 Mar; 83(3):1066-72. PubMed ID: 2466049
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies against cytochromes P-4502E1 and P-4503A in alcoholics.
Lytton SD; Helander A; Zhang-Gouillon ZQ; Stokkeland K; Bordone R; Aricò S; Albano E; French SW; Ingelman-Sundberg M
Mol Pharmacol; 1999 Feb; 55(2):223-33. PubMed ID: 9927612
[TBL] [Abstract][Full Text] [Related]
19. Differences in immune recognition of cytochrome P4502D6 by liver kidney microsomal (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infection.
Ma Y; Peakman M; Lobo-Yeo A; Wen L; Lenzi M; Gäken J; Farzaneh F; Mieli-Vergani G; Bianchi FB; Vergani D
Clin Exp Immunol; 1994 Jul; 97(1):94-9. PubMed ID: 8033426
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450 2A6: a new hepatic autoantigen in patients with chronic hepatitis C virus infection.
Dalekos GN; Obermayer-Straub P; Bartels M; Maeda T; Kayser A; Braun S; Loges S; Schmidt E; Gershwin ME; Manns MP
J Hepatol; 2003 Nov; 39(5):800-6. PubMed ID: 14568264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
